• / Free eNewsletters & Magazine
  • / My Account
Home>Wear a Pink Exos Wrist Brace in October; Join the Fight against Breast and Ovarian Cancer

Wear a Pink Exos Wrist Brace in October; Join the Fight against Breast and Ovarian Cancer

Wear a Pink Exos Wrist Brace in October; Join the Fight against Breast and Ovarian Cancer

10/06/2017

Wear a Pink Exos Wrist Brace in October; Join the Fight against Breast and Ovarian Cancer

DJO Global to donate 10 percent of Exos Upper Extremity ‘PINK’ products sold in October

DJO Global, Inc. (“DJO Global” or the “Company”), a leading global provider of medical technologies designed to get and keep people moving, announces a promotion for October that will help support breast and ovarian health education. Exos, part of the DJO Global family of brands, has partnered with Bright Pink® to educate more young women and health providers, and inspire women to make changes that could save their lives.

This press release features multimedia. View the full release here: http://www.businesswire.com/news/home/20171006005637/en/

Exos Upper Extremity Wrist Brace (Photo: Business Wire)

Exos Upper Extremity Wrist Brace (Photo: Business Wire)

An estimated one in eight women will be diagnosed with breast cancer in their lifetime. And ovarian cancer is the deadliest gynecological disease; two-thirds of those diagnosed will die as a result. But Bright Pink focuses on health, not cancer.

“Many people have been impacted by breast cancer or ovarian cancer, either personally or by seeing loved ones confront the disease,” said Kevin Brothen, Vice President of Marketing, Bracing and Supports. “Our company champions a proactive approach to health and wellness, and this campaign aligns with that philosophy. By increasing awareness about issues such as prevention and early detection, we can all help make a difference.”

DJO Global will donate 10 percent of all Exos Upper Extremity “PINK” products sold this October to Bright Pink. Bright Pink focuses on prevention and early detection of breast cancer and ovarian cancer in women age 18-45. The goal is to foster a supportive healthcare relationship where informed women have proactive conversations with trusted healthcare providers on a regular basis.

©2017 Morningstar Advisor. All right reserved.